Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 11 2021
Historique:
received: 30 07 2021
accepted: 22 10 2021
entrez: 6 11 2021
pubmed: 7 11 2021
medline: 24 12 2021
Statut: epublish

Résumé

Remdesivir is an antiviral approved for COVID-19 treatment, but its wider use is limited by intravenous delivery. An orally bioavailable remdesivir analog may boost therapeutic benefit by facilitating early administration to non-hospitalized patients. This study characterizes the anti-SARS-CoV-2 efficacy of GS-621763, an oral prodrug of remdesivir parent nucleoside GS-441524. Both GS-621763 and GS-441524 inhibit SARS-CoV-2, including variants of concern (VOC) in cell culture and human airway epithelium organoids. Oral GS-621763 is efficiently converted to plasma metabolite GS-441524, and in lungs to the triphosphate metabolite identical to that generated by remdesivir, demonstrating a consistent mechanism of activity. Twice-daily oral administration of 10 mg/kg GS-621763 reduces SARS-CoV-2 burden to near-undetectable levels in ferrets. When dosed therapeutically against VOC P.1 gamma γ, oral GS-621763 blocks virus replication and prevents transmission to untreated contact animals. These results demonstrate therapeutic efficacy of a much-needed orally bioavailable analog of remdesivir in a relevant animal model of SARS-CoV-2 infection.

Identifiants

pubmed: 34741049
doi: 10.1038/s41467-021-26760-4
pii: 10.1038/s41467-021-26760-4
pmc: PMC8571282
doi:

Substances chimiques

Antiviral Agents 0
Prodrugs 0
GS-441524 1BQK176DT6
Adenosine K72T3FS567

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6415

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI141222
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI161175
Pays : United States
Organisme : Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
ID : AI141222
Organisme : Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID)
ID : AI153400

Informations de copyright

© 2021. The Author(s).

Références

Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33558299
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Science. 2021 Jan 8;371(6525):172-177
pubmed: 33172935
J Med Chem. 2021 Apr 22;64(8):5001-5017
pubmed: 33835812
J Med Chem. 2017 Mar 9;60(5):1648-1661
pubmed: 28124907
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
Clin Transl Sci. 2020 Sep;13(5):896-906
pubmed: 32589775
J Clin Microbiol. 2016 Dec 28;55(1):177-182
pubmed: 27795347
J Infect Dis. 2021 Apr 8;223(7):1132-1138
pubmed: 33388780
Methods Mol Biol. 2012;838:369-84
pubmed: 22228022
Bioorg Med Chem. 2021 Sep 15;46:116364
pubmed: 34450570
Clin Pharmacokinet. 2021 May;60(5):569-583
pubmed: 33782830
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
J Virol. 2005 Mar;79(6):3846-50
pubmed: 15731278
mBio. 2020 May 22;11(3):
pubmed: 32444382
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
J Biol Chem. 2020 Nov 20;295(47):16156-16165
pubmed: 32967965
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
mBio. 2018 Mar 6;9(2):
pubmed: 29511076
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
pubmed: 32054787
J Med Chem. 2021 Feb 1;:
pubmed: 33523654
Science. 2021 May 21;372(6544):815-821
pubmed: 33853970
Clin Immunol. 2020 Nov;220:108588
pubmed: 32905851
Nat Microbiol. 2021 Jan;6(1):11-18
pubmed: 33273742
Sci Transl Med. 2019 Oct 23;11(515):
pubmed: 31645453
Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26946-26954
pubmed: 33028676
J Clin Microbiol. 2020 Dec 17;59(1):
pubmed: 33046529
Science. 2020 May 29;368(6494):1016-1020
pubmed: 32269068
Antimicrob Agents Chemother. 2021 Mar 1;:
pubmed: 33649113
Bioinformatics. 2009 Sep 1;25(17):2283-5
pubmed: 19542151
PLoS Pathog. 2021 Jan 28;17(1):e1009292
pubmed: 33507952
Cell Rep. 2020 Jul 21;32(3):107940
pubmed: 32668216
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Nat Med. 2021 Mar;27(3):401-410
pubmed: 33723456
J Biol Chem. 2020 May 15;295(20):6785-6797
pubmed: 32284326
Nature. 2020 Sep;585(7824):273-276
pubmed: 32516797
Nat Commun. 2021 Mar 12;12(1):1653
pubmed: 33712573

Auteurs

Robert M Cox (RM)

Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.

Josef D Wolf (JD)

Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.

Carolin M Lieber (CM)

Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.

Julien Sourimant (J)

Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.

Michelle J Lin (MJ)

Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

Darius Babusis (D)

Gilead Sciences Inc, Foster City, CA, USA.

Venice DuPont (V)

Gilead Sciences Inc, Foster City, CA, USA.

Julie Chan (J)

Gilead Sciences Inc, Foster City, CA, USA.

Kim T Barrett (KT)

Gilead Sciences Inc, Foster City, CA, USA.

Diane Lye (D)

Gilead Sciences Inc, Foster City, CA, USA.

Rao Kalla (R)

Gilead Sciences Inc, Foster City, CA, USA.

Kwon Chun (K)

Gilead Sciences Inc, Foster City, CA, USA.

Richard L Mackman (RL)

Gilead Sciences Inc, Foster City, CA, USA.

Chengjin Ye (C)

Texas Biomedical Research Institute, San Antonio, TX, USA.

Tomas Cihlar (T)

Gilead Sciences Inc, Foster City, CA, USA.

Luis Martinez-Sobrido (L)

Texas Biomedical Research Institute, San Antonio, TX, USA.

Alexander L Greninger (AL)

Virology Division, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.

John P Bilello (JP)

Gilead Sciences Inc, Foster City, CA, USA.

Richard K Plemper (RK)

Center for Translational Antiviral Research, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA. rplemper@gsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH